Publications:
Our Research

Filter

Filter

Research Area
Technology
Resource type
Category
216 results found
Apr 12, 2017
Publication
Novavax led
Immunity & Ageing
RSV
Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults
Fries, Louis , Shinde, Vivek, Stoddard, Jeffrey J., et al.
May 25, 2016
Presentation
RSV, Matrix-M® adjuvant
Recombinant Nanoparticle Vaccines: Respiratory and Emerging Viruses

Keystone Symposia: New Approaches to Vaccines for Human and Veterinary Tropical Disease

Fries, Louis
Feb 24, 2016
Publication
Novavax led
Ebola, Matrix-M® adjuvant
Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice
Nov 9, 2015
Presentation
Ebola
Rapid Responses to Novel Lethal Viruses: The Potential of Recombinant Nanoparticle Vaccines Produced in Sf9 Insect Cells

World Vaccine Congress

Glenn, Gregory, et al.
Oct 9, 2015
Presentation
Ebola
Novavax Ebola/Makona Glycoprotein (GP) Nanoparticle Vaccine Candidate Update: NHP and Clinical Data

WHO 5th Teleconference on Ebola Vaccine Clinical Trials

Oct 9, 2015
Presentation
RSV
RSV F Vaccine: Phase 2 Clinical Trial to Protect Infants via Maternal Immunization

FIGO World Congress of Gynecology and Obstetrics

August, Allison
Aug 28, 2015
Publication
Novavax led
Vaccine
RSV
Modeling maternal fetal RSV F vaccine induced antibody transfer in guinea pigs
Glenn, Gregory M., Fries, Louis F., Smith, Gale, et al.
Aug 10, 2015
Publication
Novavax led
The Journal of Infectious Diseases
RSV
A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age
Glenn, Gregory M., Fries, Louis F., Thomas, D. Nigel, et al.
May 7, 2015
Presentation
Ebola
Rapid Responses to Novel Lethal Viruses: The Potential of Recombinant Nanoparticle Vaccines Produced in a Baculovirus Insect Cell System

Atlantic Vaccines Summit & Immunotherapeutics Summit

Glenn, Gregory, et al.
Apr 7, 2015
Presentation
RSV
RSV F Nanoparticle Vaccine: Biological Rationale, Summary of the Clinical Data and Path Forward

World Vaccine Congress

Glenn, Gregory, et al.